Gary Charles Robb - 08 Jun 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Jun 2023, 21:15:30 UTC
Prior SEC filing
05 Jun 2023
Next SEC filing
16 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Filing notes and source

Key filing fact

Gary Charles Robb filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 12 Jun 2023.

Key facts

  • This page summarizes Gary Charles Robb's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
  • 8 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Jun 2023, 21:15.

Change

  • Previous filing in this sequence was filed on 05 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
-725
Change %
-3%
Price
$0.000000
Shares after
23,454
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
-725
Change %
-3.1%
Price
$0.000000
Shares after
22,729
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
-725
Change %
-3.2%
Price
$0.000000
Shares after
22,004
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
-725
Change %
-3.3%
Price
$0.000000
Shares after
21,279
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
-650
Change %
-3.1%
Price
$0.000000
Shares after
20,629
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
+725
Change %
+9.9%
Price
$0.000000
Shares after
8,061
Date
08 Jun 2023
Ownership
Custodial Account for Child
Footnotes
F2
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
+725
Change %
+9.9%
Price
$0.000000
Shares after
8,061
Date
08 Jun 2023
Ownership
Custodial Account for Child
Footnotes
F2
CORT transaction

Common Stock

Gift

Transaction value
$0
Shares
+725
Change %
+9.9%
Price
$0.000000
Shares after
8,061
Date
08 Jun 2023
Ownership
Custodial Account for Child
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Footnote F2

These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .